Status:
COMPLETED
Immunogenicity After Two Doses of Meningococcal Outer Membrane Vesicle Vaccine MenBVac
Lead Sponsor:
University Hospital, Rouen
Conditions:
Vaccination
Eligibility:
All Genders
2-7 years
Brief Summary
The main objective of the study is to estimate the proportion of children, born between the 01/01/2002 and the 06/23/200, living around Dieppe (cantons Dieppe est, Dieppe Ouest and Offranville), vacci...
Eligibility Criteria
Inclusion
- children born between 01/01/2000 and 06/23/2005, living in Dieppe-Est, Dieppe-Ouest and Offranville, vaccinated twice by MenBVac
- parental authority(ies)assent
Exclusion
- no parental authority(ies)assent
- no blood sample during the third vaccination
- impossibility of third vaccination
Key Trial Info
Start Date :
February 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
236 Patients enrolled
Trial Details
Trial ID
NCT00450554
Start Date
February 1 2007
End Date
May 1 2008
Last Update
March 27 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UH-rouen
Rouen, Seine Maritime, France, 76000